Skip to main content

23andMe to Be Bought by Biotech Company for $256 Million

23andMe to Be Bought by Biotech Company for $256 Million
By Michael Levenson from NYT Business https://ift.tt/i68KZqT
Bankruptcies, Mergers, Acquisitions and Divestitures, Genetics and Heredity, Privacy, 23andMe, Regeneron Pharmaceuticals Inc, Bonta, Rob (1972- ), Wojcicki, Anne, Yancopoulos, George D, Tarrytown (NY), DNA (Deoxyribonucleic Acid)
Labels:

Comments

Post a Comment

Popular posts from this blog

Building a Security Feedback Process for DevOps

The last few years have seen some major slip-ups in the security space among all major cloud providers, resulting in uncertainty and speculation. That’s understanding; cloud security is an extremely complicated subject as enterprises build and deploy applications faster than ever before to keep up with business requirements. Most of the security issues that occur […] The post Building a Security Feedback Process for DevOps appeared first on DevOps.com . from DevOps.com http://bit.ly/2L1DS7t
Post a Comment
Read more

How to Overcome Resistance to DevOps Implementation

The number of businesses adopting DevOps to make software releases happen faster without compromising on software quality continues to grow. Within the next five years, the DevOps market is expected to reach almost $13 billion. If you are among those who’ve decided to make a shift to DevOps, you are likely to experience resistance coming […] The post How to Overcome Resistance to DevOps Implementation appeared first on DevOps.com . from DevOps.com https://ift.tt/34KjEGQ
Post a Comment
Read more